Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

SenoRx, a company that is exclusively focused on breast cancer, has developed a new RFID Tag device that could soon be the next innovative product to come out of their robust R&D pipeline.

In the growing category of women's oncological needs, introduction of new technologies are paramount to better care for the patient and for the corporate health of the companies pioneering the innovation. RFID Tag device can be an sufficient product to meet the specific needs. For women's health, the device could be extremely important and beneficial. For SenoRx and its shareholders, completion of the product development would be another in a series of achievements by the company and continuing evidence of their ability to capitalize on a broad and innovative pipeline for new products to further strengthen and expand the SenoRx brand - all while helping doctors treat patients more effectively.

SenoRx recently announced that it was conducting market research for a new RFID tag and accompanying handheld reader which the company believes may be the next generation lesion localization device. The benefits of the device may offer significant improvements in scheduling logistics and workflow between the radiologist and surgeon. Also since the RFID tag is contained inside the patient's breast, there is no protruding wire common in similar procedures today, thus potentially reducing the risk of infection and the urgency to perform the surgical procedure the same day. In the current course of treatment it is imperative that a patient rapidly go from radiologist to surgeon to minimize risk of infection and patient discomfort.

It is a clear market opportunity for SenoRx with over a half million lumpectomies and excisional biopsies each year. But more importantly, successful adaptation of the device would further SenoRx's leadership in women's oncology, adding another innovation to its roster of successes that include achievements in minimally invasive tissue removal technologies and implantables.

SenoRx has a rich history of successful innovative product developments focused on the breast cancer arena, offering health care providers both diagnostic and therapeutic technologies to better detect and treat breast cancer, the second most frequently diagnosed cancer among women.

Source:Globe NewsWire

You can discuss more about SenoRx and its services in the SenoRx Company User Group.